JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.

Andere Sprachen Jilin Aodong Pharmaceutical Group Co., Ltd.

Aktien

000623

CNE000000719

000623

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 19.06.2024			% 5 Tage	% 1. Jan.
13,9 ^CNY	-0,86 %		+0,36 %	-8,19 %

23.05.	Aodong Medicine Industry's Unit erhält Zertifikate für 10 traditionelle chinesische Arzneimittel	MT
29.04.	Jilin Aodong Pharmaceutical Group Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Aodong Medicine Industry's Unit Gets Certificates for 10 Traditional Chinese Medicines	23.05.
Jilin Aodong Pharmaceutical Group Co., Ltd. Approves Dividend for the Year 2023	20.05.
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20%	17.04.
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	17.11.
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on September 21, 2023, has closed with 9,015,780 shares, representing 0.8% for CNY 150 million.	17.11.
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30.10.23
Chinese listed firms used endangered animal parts as ingredients -report	23.10.23
Three listed Chinese firms used endangered animal parts as ingredients- report	23.10.23
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.	09.10.23
Jilin Aodong Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.	20.09.23
Jilin Aodong Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan.	20.09.23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders.	04.09.23
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30.08.23
Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Jilin Aodong Pharmaceutical Group Co., Ltd.	30.08.23
Jilin Aodong Pharmaceutical Group Co., Ltd. Elects Liang Biming as Independent Director	18.07.23
Aodong Medicine's Unit Gets Registration Certificate for 16 Formula Tablets	05.07.23
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 7, 2023	29.06.23
Jilin Aodong Pharmaceutical Group Co., Ltd Approves the Profit Distribution Proposal for 2022	16.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Jilin Aodong Pharmaceutical Group Co., Ltd.

Aktien

000623

CNE000000719

000623

Andere Sprachen

Filter